Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D.
| Corporate Author: | United States. Department of Health and Human Services. Office of Inspector General (Author) |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
[Washington, D.C.] :
Department of Health and Human Services, Office of Inspector General,
2011.
|
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/gpo68404 |
Similar Items
Medicaid brand-name drugs : rising prices are offset by manufacturer rebates.
Published: (2011)
Published: (2011)
States' use of new drug pricing data in the Medicaid program.
Published: (2007)
Published: (2007)
1999 Medicare and Medicaid benefits.
Published: (1999)
Published: (1999)
Medicare and Medicaid.
Published: (1970)
Published: (1970)
Protecting Medicare and Medicaid : Efforts To Prevent, Investigate, and Prosecute Health Care Fraud.
Published: (2012)
Published: (2012)
Medicare and Medicaid Program Integrity : Combating Improper Payments and Ineligible Providers.
Published: (2016)
Published: (2016)
Comparison of Medicaid federal upper limit amounts to average manufacturer prices.
Published: (2005)
Published: (2005)
Monitoring Medicare Part B drug prices : a comparison of average sales prices to average manufacturer prices.
Published: (2006)
Published: (2006)
Calculation of volume-weighted average sales price for Medicare Part B prescription drugs.
Published: (2006)
Published: (2006)
Medicaid drug price comparisons : average manufacturer price to published prices.
Published: (2005)
Published: (2005)
Medicaid's use of revised average wholesale prices.
Published: (2001)
Published: (2001)
Medicaid drug price comparisons : average sales price to average wholesale price.
Published: (2005)
Published: (2005)
Medicaid prescription drug pricing and policy /
by: Binder, Cliff
Published: (2019)
by: Binder, Cliff
Published: (2019)
Comparing pharmacy reimbursement : Medicare Part D to Medicaid.
Published: (2009)
Published: (2009)
Medicaid, getting started /
Published: (2009)
Published: (2009)
How inflated published prices affect drugs considered for the federal upper limit list.
Published: (2005)
Published: (2005)
Medicare, Medicaid, and other health provisions in the American Taxpayer Relief Act of 2012 /
by: Sarata, Amanda K.
Published: (2019)
by: Sarata, Amanda K.
Published: (2019)
Courts split on whether private individuals can sue to challenge states' medicaid defunding decisions : considerations for congress (part I of II) /
by: Shen, Wen S.
Published: (2018)
by: Shen, Wen S.
Published: (2018)
Courts split on whether private individuals can sue to challenge states' medicaid defunding decisions : considerations for congress (part II of II) /
by: Shen, Wen S.
Published: (2018)
by: Shen, Wen S.
Published: (2018)
The CREATES Act of 2019 and lowering drug prices : legal background and overview /
by: Shen, Wen S.
Published: (2019)
by: Shen, Wen S.
Published: (2019)
Replacing average wholesale price : Medicaid drug payment policy.
Published: (2011)
Published: (2011)
Medicare reimbursement for lupron.
Published: (2004)
Published: (2004)
[Health Cost Containment Proposals].
Published: (1979)
Published: (1979)
[Catastrophic Health Insurance Proposal].
Published: (1979)
Published: (1979)
Variation in state Medicaid drug prices.
Published: (2004)
Published: (2004)
What to do if you no longer automatically qualify for extra help with Medicare prescription drug costs.
Published: (2017)
Published: (2017)
What to do if you no longer automatically qualify for extra help with Medicare prescription drug costs.
Published: (2018)
Published: (2018)
Addition of qualified drugs to the Medicaid federal upper limit list.
Published: (2004)
Published: (2004)
Memorandum report : Medicare Part D pharmacy discounts for 2008.
Published: (2010)
Published: (2010)
Qué hacer si ya no califica automáticamente para la Ayuda Adicional con los costos de la cobertura de recetas médicas de Medicare.
Published: (2018)
Published: (2018)
Deficit Reduction Act of 2005 : impact on the Medicaid federal upper limit program.
Published: (2007)
Published: (2007)
Seniors feeling the squeeze : rising drug prices and the Part D program : hearing before the Special Committee on Aging, United States Senate, One Hundred Eleventh Congress, second session, Washington, DC, March 17, 2010.
Published: (2010)
Published: (2010)
Average sales prices : manufacturer reporting and CMS oversight.
Published: (2010)
Published: (2010)
Drug manufacturers' noncompliance with average manufacturer price reporting requirements.
Published: (2010)
Published: (2010)
Your Medicaid responsibilities : reporting changes = Obligaciones del cliente de Medicaid : reportar cambios.
Published: (1989)
Published: (1989)
Strengthening Medicare and Medicaid : taking steps to modernize America's health care system : hearing before the Committee on Finance, United States Senate, One Hundred Eleventh Congress, second session, November 17, 2010.
Published: (2010)
Published: (2010)
Public Hearing : Strengthening Publically and Privately Funded Long-Term Services and Supports.
Published: (2013)
Published: (2013)
Saving Seniors and Our Most Vulnerable Citizens from an Entitlement Crisis.
Published: (2013)
Published: (2013)
CHIP, Medicaid, Medicare, and the Health Insurance Marketplace at a glance : for American Indians and Alaska Natives.
Published: (2016)
Published: (2016)
Medicaid work requirements : an end to the litigation? /
by: Staman, Jennifer A.
Published: (2021)
by: Staman, Jennifer A.
Published: (2021)